MENU
GMAB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Genmab A/S ADS (GMAB) Earnings Date & Reports

A.I. Advisor
published Earnings

GMAB is expected to report earnings to rise 14.28% to 32 cents per share on February 12

Genmab A/S ADS GMAB Stock Earnings Reports
Q4'24
Est.
$0.33
Q3'24
Missed
by $0.02
Q2'24
Beat
by $0.01
Q1'24
Est.
$0.29
Q4'23
Missed
by $0.17
The last earnings report on November 06 showed earnings per share of 28 cents, missing the estimate of 30 cents. With 200.90K shares outstanding, the current market capitalization sits at 13.96B.
View a ticker or compare two or three
GMAB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

an international biotechnology company, which develops human antibody therapeutics for the treatment of cancer and other diseases.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Carl Jacobsens Vej 30
Phone
+45 70202728
Employees
2204
Web
https://www.genmab.com